Enhancing the clinical relevance of PANSS scores in schizophrenia

被引:0
|
作者
Campbell, BJ [1 ]
Zhu, Y [1 ]
Lasser, RA [1 ]
Smith, C [1 ]
Baldessarini, RJ [1 ]
机构
[1] Janssen Med Affairs, LLC, Titusville, NJ USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:S168 / S169
页数:2
相关论文
共 50 条
  • [1] Clinical and neuropsychological differences in schizophrenia according to negative symptom PANSS scores
    Jimenez-Arriero, M. A.
    Rodriguez-Jimenez, R.
    Rubio, G.
    Martinez, I.
    Aragues, M.
    Koeneke, A.
    Bagney, A.
    Carretero, P.
    Ponce, G.
    Palomo, T.
    EUROPEAN PSYCHIATRY, 2007, 22 : S136 - S136
  • [2] Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
    Leucht, Stefan
    Barabassy, Agota
    Laszlovszky, Istvan
    Szatmari, Balazs
    Acsai, Karoly
    Szalai, Erzsebet
    Harsanyi, Judit
    Earley, Willie
    Nemeth, Gyorgy
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (09) : 1589 - 1596
  • [3] Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
    Stefan Leucht
    Ágota Barabássy
    István Laszlovszky
    Balázs Szatmári
    Károly Acsai
    Erzsébet Szalai
    Judit Harsányi
    Willie Earley
    György Németh
    Neuropsychopharmacology, 2019, 44 : 1589 - 1596
  • [4] Correlation between vaspin and PANSS scores in schizophrenia patients with obesity
    Ertekin, Hulya
    Uysal, Sema
    Aydin, Memduha
    Ilhan, Bilge
    Ertekin, Yusuf Haydar
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2020, 55 (04): : 264 - 280
  • [5] The clinical relevance of percentage improvements on the PANSS score
    Fleischhacker, W. Wolfgang
    Kemmler, Georg
    NEUROPSYCHOPHARMACOLOGY, 2007, 32 (11) : 2435 - 2436
  • [6] The Clinical Relevance of Percentage Improvements on the PANSS Score
    W Wolfgang Fleischhacker
    Georg Kemmler
    Neuropsychopharmacology, 2007, 32 : 2435 - 2436
  • [7] Cingulate abnormalities associated with PANSS negative scores in first episode schizophrenia
    Ashton, L
    Barnes, A
    Livingston, M
    Wyper, D
    BEHAVIOURAL NEUROLOGY, 1999, 12 (1-2) : 93 - 101
  • [8] Cognitive functions and PANSS scores in a cohort of patients with schizophrenia treated with olanzapine
    Borkowska, A.
    Bielinski, M.
    Drozdz, W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S531 - S532
  • [9] Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia
    Huang, Zhiwei
    Zhang, Lei
    Li, Yan
    Yu, Yimin
    Shen, Yifeng
    Sun, Xiujia
    Lou, Kun
    Luo, Hongmei
    Meng, Zhibin
    Li, Huafang
    Wei, Yumei
    PHARMACEUTICALS, 2024, 17 (02)
  • [10] CONCURRENT VALIDITY OF THE COGNITIVE COMPONENT OF SCHIZOPHRENIA - RELATIONSHIP OF PANSS SCORES TO NEUROPSYCHOLOGICAL ASSESSMENTS
    BELL, MD
    LYSAKER, PH
    MILSTEIN, RM
    BEAMGOULET, JL
    PSYCHIATRY RESEARCH, 1994, 54 (01) : 51 - 58